Ernexa Therapeutics Inc.
ERNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | -$22 | -$25 | -$123 |
| Dep. & Amort. | $2 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $1 | $3 | $5 |
| Change in WC | -$2 | -$2 | $4 | -$2 |
| Other Non-Cash | $28 | $1 | -$4 | $96 |
| Operating Cash Flow | -$16 | -$20 | -$21 | -$23 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$23 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $5 | $17 | -$0 | -$1 |
| Stock Issued | $0 | $0 | $20 | $63 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$0 | -$0 | -$0 |
| Other Fin. Act. | $1 | -$0 | -$0 | $0 |
| Financing Cash Flow | $6 | $17 | $20 | $62 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10 | -$4 | -$1 | $15 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12 | $16 | $17 | $2 |
| End Cash | $2 | $12 | $16 | $17 |
| Free Cash Flow | -$16 | -$20 | -$21 | -$24 |